Management for males whose female partners are diagnosed with genital chlamydial infection

被引:6
|
作者
Takahashi, Satoshi [1 ]
Kurimura, Yuichiro [1 ]
Hashimoto, Jiro [1 ]
Sunaoshi, Kenichi [2 ]
Takeda, Koichi [2 ]
Suzuki, Nobukazu [2 ]
Furuya, Ryoji [3 ]
Taguchi, Keisuke [4 ]
Satoh, Takashi [5 ]
Iwasawa, Akihiko [6 ]
Hayashi, Kenji [7 ]
Hirose, Takaoki [8 ]
Tsukamoto, Taiji [1 ]
机构
[1] Sapporo Med Univ, Sch Med, Dept Urol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
[2] Teine Urol Clin, Sapporo, Hokkaido, Japan
[3] Furuya Hosp, Kitami, Hokkaido, Japan
[4] Oji Gen Hosp, Dept Urol, Tomakomai, Japan
[5] Nisshin Urol Clin, Tomakomai, Japan
[6] Iwasawa Clin, Sapporo, Hokkaido, Japan
[7] Tomakomai Urol Clin, Tomakomai, Japan
[8] Hokkaido Social Insurance Hosp, Dept Urol, Sapporo, Hokkaido, Japan
关键词
Asymptomatic infection; Chlamydia trachomatis; Sexual transmitted disease (STD); Pyuria;
D O I
10.1007/s10156-010-0083-3
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The purpose of this study was to investigate the infection rate of asymptomatic men whose female sexual partners were diagnosed as having genital chlamydial infection and discuss the management for them. The subjects were asymptomatic men whose female sexual partners were diagnosed with genital chlamydial infection at other obstetric and gynecological clinics. Microscopic findings of urinary sediment and the results of a nucleic acid amplification test of the first-voided urine specimen were retrospectively examined in those men who visited our clinics. A total of 267 men were included and analyzed. The infection rate for urinary Chlamydia trachomatis in asymptomatic men was 36.3% (97 of 267). In the analysis of urinary sediment, 35 of the 267 (13.1%) had pyuria and 82.9% (29 of 35) in the men with pyuria were positive for urinary C. trachomatis in. Even in men without pyuria, the urinary C. trachomatis-positive rate was 29.3% (68 of 232). When such men have pyuria in the clinic, prompt treatment is the appropriate approach. If the men are without pyuria, testing for urinary C. trachomatis should be performed. Prompt treatment before doing any clinical evaluation can be an option in couples with trouble.
引用
收藏
页码:76 / 79
页数:4
相关论文
共 50 条
  • [41] Accelerating the audit cycle: data gathering, analysis and dissemination of results by electronic methods. The third Yorkshire audit of genital chlamydial management
    McClean, H
    Haworth, P
    Clarke, J
    INTERNATIONAL JOURNAL OF STD & AIDS, 2004, 15 (11) : 767 - 771
  • [42] Study of the prevalence and association of ocular chlamydial conjunctivitis in women with genital infection by Chlamydia trachomatis, Mycoplasma genitalium and Candida albicans attending outpatient clinic
    Rania Abdelmonem Khattab
    Maha Mohssen Abdelfattah
    International Journal of Ophthalmology, 2016, (08) : 1176 - 1186
  • [43] Study of the prevalence and association of ocular chlamydial conjunctivitis in women with genital infection by Chlamydia trachomatis, Mycoplasma genitalium and Candida albicans attending outpatient clinic
    Khattab, Rania Abdelmonem
    Abdelfattah, Maha Mohssen
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2016, 9 (08) : 1176 - 1186
  • [44] Transient Detection of Chlamydial-Specific Th1 Memory Cells in the Peripheral Circulation of Women with History of Chlamydia trachomatis Genital Tract Infection
    Miguel, Rodolfo D. Vicetti
    Reighard, Seth D.
    Chavez, Jean M.
    Rabe, Lorna K.
    Maryak, Samantha A.
    Wiesenfeld, Harold C.
    Cherpes, Thomas L.
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2012, 68 (06) : 499 - 506
  • [45] Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection
    Jiang, Pengfei
    Du, Wangqi
    Xiong, Yirong
    Lv, Yan
    Feng, Juan
    Zhu, Shanli
    Xue, Xiangyang
    Chen, Shao
    Zhang, Lifang
    ONCOTARGET, 2015, 6 (41) : 43281 - 43292
  • [46] PROTECTIVE EFFICACY OF A PARENTERALLY ADMINISTERED MOMP-DERIVED SYNTHETIC OLIGOPEPTIDE VACCINE IN A MURINE MODEL OF CHLAMYDIA-TRACHOMATIS GENITAL-TRACT INFECTION - SERUM NEUTRALIZING IGG ANTIBODIES DO NOT PROTECT AGAINST CHLAMYDIAL GENITAL-TRACT INFECTION
    SU, H
    PARNELL, M
    CALDWELL, HD
    VACCINE, 1995, 13 (11) : 1023 - 1032
  • [47] Type-I Interferon Signaling Protects against Chlamydia trachomatis Infection in the Female Lower Genital Tract
    He, Rongze
    Torres, Caroline Andrea
    Wang, Yihui
    He, Cheng
    Zhong, Guangming
    INFECTION AND IMMUNITY, 2023, 91 (06)
  • [48] Hepatitis B core virus-like particles bearing Pgp3 antigen enhance immune response against genital chlamydial infection in mice
    Wang, Xinglv
    Shi, Keliang
    Zhao, Lanhua
    Cheng, Shan
    Chen, Lili
    Li, Zhongyu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 146
  • [49] Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice
    Joseph M Lyons
    Servaas A Morré
    Lucy P Airo-Brown
    A Salvador Peña
    James I Ito
    BMC Infectious Diseases, 5
  • [50] A multi-district audit against national guidelines for the management of uncomplicated genital Chlamydia trachomatis infection
    Clarke, J
    Preston, AD
    INTERNATIONAL JOURNAL OF STD & AIDS, 2001, 12 (10) : 677 - 686